To determine the impact of Abi1 disruption on mammary tumor initiation and progression, we used our Abi1 KO mouse model to study the impact of Abi1 loss on tumor progression and characteristics in the PyMT‐driven breast cancer. This evidence concerns the gene ABI1 and neoplasm.